MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$1,705,071K
Net Income
$237,007K
Net Profit Margin
13.90%
EPS
$0.16
Unit: Thousand (K) dollars
Revenue Breakdown
US
CN
Europe
All Other Countries Except China...
Revenue Breakdown
BRUKINSA
TEVIMBRA
XGEVA
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Total revenues
1,705,071
1,513,438
1,498,170
1,412,284
Cost of sales - product
174,530
167,215
142,422
196,510
Gross profit
1,530,541
1,346,223
1,355,748
1,215,774
Research and development
612,280
541,224
615,423
523,662
Selling, general and administrative
593,214
555,097
555,290
528,998
Total operating expenses
1,205,494
1,096,321
1,170,713
1,052,660
Income from operations
325,047
249,902
185,035
163,114
Interest income
27,900
27,664
14,456*
-
Interest income, net
-
-
-
3,029
Interest expense
39,739
32,887
14,559*
-
Other (expense) income, net
-749
14,536
-35,691
-18,979
Income before income taxes
312,459
259,215
149,241
147,164
Income tax expense
75,452
31,858
82,739
22,323
Net income
237,007
227,357
66,502
124,841
Basic EPS
0.16
0.16
0.046
0.09
Diluted EPS
0.16
0.15
0.044
0.08
Basic Average Shares
1,450,485,552
1,442,451,870
1,440,193,489
1,432,801,699
Diluted Average Shares
1,505,361,900
1,505,027,338
1,502,038,658
1,488,750,354
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
1
2
Product
$898,616K
(31.11%↑ Y/Y)
Other Revenue
$15,589K
Product
$499,714K
(16.54%↑ Y/Y)
Other Revenue
$6,307K
Product
$208,403K
(36.82%↑ Y/Y)
Other Revenue
$352K
Product
$73,061K
(105.43%↑ Y/Y)
Other Revenue
$3,029K
US
$914,205K
(31.65%↑ Y/Y)
CN
$506,021K
(16.88%↑ Y/Y)
Europe
$208,755K
(36.99%↑ Y/Y)
All Other Countries
Except China And United...
$76,090K
(113.95%↑ Y/Y)
Total revenues
$1,705,071K
(29.63%↑ Y/Y)
Gross profit
$1,530,541K
(33.01%↑ Y/Y)
Cost of sales -
product
$174,530K
(6.03%↑ Y/Y)
Income from operations
$325,047K
(269.85%↑ Y/Y)
Interest income
$27,900K
Total operating
expenses
$1,205,494K
(13.43%↑ Y/Y)
Income before income
taxes
$312,459K
(213.87%↑ Y/Y)
Interest expense
$39,739K
Other (expense)
income, net
-$749K
(-109.17%↓ Y/Y)
Research and development
$612,280K
(16.65%↑ Y/Y)
Selling, general and
administrative
$593,214K
(10.28%↑ Y/Y)
Net income
$237,007K
(151.28%↑ Y/Y)
Income tax expense
$75,452K
(1342.95%↑ Y/Y)
Buy us a coffee
BeOne Medicines Ltd. (BEIGF)
BeOne Medicines Ltd. (BEIGF)